Testosterone (Testosterone)

Quick links to important sections

Testosterone (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Testosterone (Testosterone)

Property Description
Active ingredient Testosterone or Testosterone esters (e.g., Cypionate, Enanthate)
Form Injectable solution, Topical gel/cream, Transdermal patch, Buccal tablet, Oral capsule
Pharmacological class Androgen (Sex hormone)
General purpose Hormone Replacement for Androgen Deficiency
Origin Bioidentical (chemically identical to natural hormone), prepared synthetically

What Type of Medicine is Testosterone (Testosterone)?

Testosterone medication is primarily classified as an androgen and a fundamental sex hormone, belonging to the steroid hormone class. The active compound is chemically bioidentical to the endogenous hormone naturally produced by the human body. While bioidentical, it is manufactured through synthetic or semi-synthetic processes for clinical use. The core active ingredient is often formulated as derivatives known as esters—such as Testosterone Cypionate or Testosterone Enanthate—which are designed to modulate the rate at which the hormone is released into the bloodstream, ensuring therapeutic stability. Testosterone is classified as an Androgenic Agent used for replacement therapy.


What Forms and Preparations Does Testosterone Use?

Testosterone is available across multiple distinct dosage forms, facilitating various routes of administration, including injections, topical application, and oral delivery. These are typically single-ingredient products with compositions that vary by the base or vehicle used. For instance, injectable solutions are often oil-based (parenteral administration), while topical gels or creams use a hydroalcoholic base for absorption through the skin (transdermal administration). Other preparations include transdermal patches, buccal tablets, and specialized oral capsules, providing flexibility in hormone administration to suit individual patient needs and optimize the consistency of systemic testosterone levels.


What is the General Purpose of Testosterone Therapy?

The general therapeutic purpose of administering Testosterone is to provide hormonal replacement and activate the body’s anabolic processes in individuals diagnosed with insufficient natural hormone production, a condition known as hypogonadism. The medicine's fundamental function involves binding to Androgen Receptors to initiate effects that drive protein synthesis and promote nitrogen retention. This action is essential for restoring physiological balance, supporting the maintenance of muscle mass and bone density, and sustaining overall physical function compromised by androgen deficiency. This mechanism serves as the foundation for Testosterone Replacement Therapy (TRT), a standard approach when the body's natural production is compromised.

What side effects are possible with Testosterone (Testosterone)?

Possible side effects and safety information

The official safety profile for Testosterone is structured by regulatory bodies, classifying adverse reactions by frequency and affected body systems. These classifications distinguish between expected changes and serious documented risks.


Frequency-Classified Adverse Reactions

Side effects are categorized by frequency in official documents. Very common events (occurring in more than 1 in 10 patients) include an increase in hematocrit, red cell count, and hemoglobin. Common reactions (occurring in up to 1 in 10 patients) include changes such as acne, headache, fluid retention, weight increase, gynecomastia (male breast enlargement), and prostatic disorders like prostatic hypertrophy and increased Prostate-Specific Antigen (PSA) levels. Rare effects, such as hepatic dysfunction, are also documented.


System-Organ Classes and Serious Adverse Reactions

Adverse effects are documented across several physiological systems, including Blood and Lymphatic System disorders (polycythemia), Skin and Subcutaneous Tissue disorders, and Reproductive System disorders.

Serious adverse reactions highlighted in regulatory documents include the risk of Venous Thromboembolism (VTE), which encompasses Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). There is also a risk of exacerbation of known or suspected prostate or male breast carcinoma and the potential for Sleep Apnea exacerbation.


Population-Specific Safety Considerations

Specific safety considerations are noted for defined patient groups. Geriatric patients require close monitoring for prostatic disorders and related PSA increases. Use in pediatric patients must be monitored for the risk of premature epiphyseal closure, which can affect growth. Furthermore, patients with pre-existing cardiac, renal, or hepatic disease must be monitored carefully due to the potential for fluid retention leading to edema, which may worsen heart conditions.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Testosterone products is defined by the clinical consequences of hormone excess. Officially documented clinical signs of excess androgen exposure include priapism (a prolonged, painful erection), gynecomastia (breast enlargement), and polycythemia (abnormally increased red blood cell mass indicated by high hematocrit).

Required Emergency Actions

Regulatory authorities mandate that immediate medical attention must be sought for symptoms indicative of severe or life-threatening outcomes. This includes signs of stroke or myocardial infarction (such as chest pain, sudden weakness, or slurred speech), or if venous thromboembolism (VTE) is suspected.

Documented Overdose Management

Management of a confirmed overdose is primarily through discontinuation of the medicine to allow hormone levels to normalize. The required procedural step is to provide symptomatic and supportive treatment, as official regulatory documentation states that no specific antidote is known for testosterone overdose.

Population-Specific Risks

In pediatric patients, androgen excess presents a significant risk for irreversible outcomes, specifically acceleration of bone age and premature closure of the epiphyses. Patients with pre-existing cardiac, renal, or hepatic disease are also at increased risk for severe edema, which may lead to or exacerbate congestive heart failure.

Therapeutic Uses of Testosterone (Testosterone)

Testosterone Replacement Therapy (TRT) is commonly used to address the systemic effects of confirmed androgen deficiency (hypogonadism), focusing on supporting the patient in managing symptoms that interfere with daily functioning and create noticeable physiological strain. The therapy is primarily used to treat low or absent testosterone levels, address developmental lag, and manage certain types of breast cancer.

The therapy is applied in addressing conditions characterized by periods of heightened symptoms such as loss of muscle mass and strength, decreased bone mineral density, and issues with sexual desire and erectile function. Furthermore, it is relevant for easing neurocognitive symptoms like chronic fatigue, lethargy, and fluctuations in mood or concentration.

“This therapy is commonly used in areas where additional symptomatic support is needed.”

The treatment helps support the patient by contributing to easing discomfort related to sexual health and vitality, and assists with maintaining physical and emotional stability. It is also applied in addressing developmental lag in adolescent males with Constitutional Delay of Growth and Puberty and for specific clinical deficits like Klinefelter Syndrome.

Quick Fact: Support for Fatigue and Low Libido

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Testosterone (Testosterone)?

Testosterone is a prescription medicine governed by strict regulatory eligibility rules that define who can be treated and who must be excluded. Use is primarily approved for adult males with laboratory-confirmed testosterone deficiency, known as hypogonadism. Conditional, short-term use may also be permitted for adolescent males with Constitutional Delay of Growth and Puberty.


Absolute Contraindications

Testosterone is absolutely contraindicated (prohibited) in the following populations:

  • Males with known or suspected carcinoma of the breast or prostate.
  • Women who are pregnant or breastfeeding, due to the high risk of fetal harm (virilization) or harm to the nursing infant.
  • Individuals with a known hypersensitivity to the active ingredient or any excipients.

Conditional Use and Restrictions

Use is restricted or requires extreme caution for several groups, including:

  • Older men (Geriatric Population): Requires increased monitoring, particularly of prostate health.
  • Patients with Severe Cardiac, Hepatic, or Renal Disease: Requires extreme caution due to the risk of exacerbating edema (fluid retention) and potentially heart failure.

Official regulatory bodies state that the safety and effectiveness of Testosterone for treating low levels due solely to aging have not been established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies specific pharmacodynamic and metabolic interactions for testosterone with other medicinal products. These interactions typically necessitate increased clinical monitoring and potential regimen adjustments, but are not classified as absolute contraindications.


Documented Interaction Patterns

Interacting Agent Category Officially Documented Interaction Pattern
Oral Anticoagulants (e.g., Warfarin) Testosterone may increase sensitivity to these agents. This interaction is associated with an increase in Prothrombin Time (PT) and International Normalized Ratio (INR), requiring close monitoring.
Antidiabetic Agents (e.g., Insulin) Androgens may decrease blood glucose levels. This metabolic effect requires consideration for potential dosage adjustment of the antidiabetic regimen.
Corticosteroids and ACTH Co-administration may result in increased fluid retention and edema due to additive steroidal effects (a pharmacodynamic interaction).

Interaction-Related Constraints and Considerations

No mandatory timing-based separation rules for administration are cited in regulatory summaries. However, the fluid retention interaction with Corticosteroids is noted as a specific consideration for patients with pre-existing cardiac, renal, or hepatic disease. Regulatory requirements mandate frequent monitoring of coagulation markers when co-administering with oral anticoagulants, and assessment of blood glucose levels when co-administering antidiabetic agents.

Mechanism of Action

Testosterone, an androgen, functions primarily as an agonist for the Androgen Receptor (AR), a ligand-activated nuclear receptor. Upon entering target cells via passive diffusion or transporter proteins, testosterone can either bind directly to the cytoplasmic AR or be locally converted by the enzyme 5alpha-reductase into the more potent AR agonist, dihydrotestosterone (DHT).

The androgen-receptor complex subsequently translocates from the cytoplasm into the cell nucleus. Within the nucleus, the complex binds to specific DNA sequences known as Androgen Response Elements (AREs) located in the promoter regions of target genes. This binding event modulates gene transcription, leading to an increase or decrease in the messenger RNA (mRNA) and subsequent protein synthesis of various cellular components. Downstream genomic cascades regulate processes such as protein anabolism, erythropoiesis, bone matrix formation, and the development and maintenance of primary and secondary sex characteristics. The ultimate system-level physiological consequence involves the modulation of muscle mass, bone density, hematopoiesis, and the maintenance of reproductive tissues.

Dosage and Administration Information

How to Use Testosterone (Testosterone)

Testosterone replacement therapy is administered through several administration routes, each with specific dosing schedules and administration requirements.


Administration Routes and Frequency Patterns

The choice of formulation determines both the route and the frequency of use. Oral capsules (Testosterone Undecanoate) are prescribed for a twice-daily schedule, while transdermal gels are applied once daily to the skin. For injectable solutions (esters like Cypionate or Enanthate), administration frequency varies, typically ranging from once weekly (subcutaneous) to every two to four weeks (intramuscular), depending on the specific product and formulation.


Contextual Use Requirements

Proper administration is conditional upon specific instructions. Oral capsules must be taken with food to ensure adequate absorption, and the dose is often split between morning and evening meals. For transdermal gels, the product must be applied to clean, dry, intact skin of approved areas (such as the upper arms or abdomen), with immediate hand washing required after application to limit potential transfer. Injectable solutions are strictly for the specified route (IM or SC); intravenous administration is forbidden.


Dosing Adjustments and Special Use

Treatment is intended for long-term replacement therapy. The initial dosage is a starting regimen that requires mandatory, periodic monitoring of serum testosterone concentrations. These hormone levels are assessed at specific post-dose or pre-dose intervals (e.g., 7 days to 6 weeks after initiation or dose change) to determine the necessity of a dose titration (adjustment). In pediatric hypogonadal males, dosing is individualized and initiated at gradually increasing levels to promote pubertal changes.

Recent Clinical Evidence

Research evidence / Overview of Studies for Testosterone (Testosterone)


Evidence for use in Confirmed Male Hypogonadism

Research has explored Testosterone in the clinical context of hypogonadism—a condition where the body does not produce enough of the hormone—primarily relying on Randomized Controlled Trials (RCTs) and Systematic Reviews that combine data from multiple studies. Research examined a range of outcomes related to sexual desire, erectile function, lean body mass, and muscle strength, as well as outcomes related to systemic or functional imbalance like bone mineral density (BMD). Findings describe patterns observed in the studies related to measurements of serum testosterone levels within the target physiological range. Studies report how symptoms evolved in the observed populations, and describe patterns related to sexual function outcomes and measurements of lean body mass during the study period. The evidence is limited regarding the long-term effects, with limited information for tracking clinical events such as the actual incidence of bone fractures or predefined long-term clinical outcomes over many years.


Evidence for use in Age-Related Decline in Testosterone

Research has explored Testosterone in the clinical context of older men who have low levels that are not due to a classic medical cause. This research involves coordinated sets of large Randomized Controlled Trials focusing on populations of older men. Research examined outcomes related to physical function, vitality, and cognitive function. Studies report how symptoms evolved in the observed populations, and data show patterns related to measurements of serum testosterone levels within the target range in treated participants. However, findings regarding outcomes such as physical function and cognitive function were often mixed or subtle across the coordinated trials. Regulatory bodies have noted that the benefit and safety are not fully established for this specific use—treating low testosterone levels simply attributed to aging.


What Research is Still Uncertain or Limited

Research describes that while there is an extensive body of evidence, certain limitations and gaps exist in the broader research landscape for Testosterone. The evidence quality varies across studies, and many results apply only to the specific populations studied. The findings were mixed or non-significant across studies that monitored patient-reported outcomes related to cognitive function and vitality in older men. Certainty remains low for long-term, definitive clinical endpoints such as the incidence of bone fractures or predefined long-term clinical outcomes, as data are still emerging from large ongoing trials designed to assess these outcomes over many years.

Key Studies & References

  1. Public Assessment Report Scientific discussion Androgel 40,5 mg, transdermal gel in sachet (testosterone) - Geneesmiddeleninformatiebank (EMA Regulatory Context)

Frequently Asked Questions (FAQ)

Common questions about Testosterone (Testosterone) (FAQ)

Q: Is Testosterone considered a controlled substance?

A: Regulatory bodies classify prescription Testosterone as a Schedule III controlled substance in the U.S. This classification is assigned to medicines that have a recognized medical use but also carry a potential for abuse or dependence. Official information notes that this medication is intended for use strictly as prescribed.

Q: What is the difference between prescription Testosterone and products found in supplements?

A: Prescription testosterone is chemically bioidentical to the hormone naturally produced by the body and is subject to strict regulatory oversight, including classification as a Schedule III controlled substance. In contrast, many products found in supplements are often unapproved compounds that are not subject to the same regulatory standards as prescription medicines. Official regulatory documents only pertain to and describe the use of prescription testosterone formulations.

Q: Is there a Black Box Warning on the FDA label for Testosterone?

A: The FDA has previously issued warnings related to the risk of heart attack and stroke associated with Testosterone. While the Black Box Warning related to these specific cardiovascular risks has been removed, official labeling requires other warnings, such as about an increased risk of blood pressure, to be included in the product information.

Q: Does Testosterone affect fertility in men?

A: While the body’s natural testosterone is essential for sperm production, the use of external prescribed testosterone can suppress the body’s own hormone production. This suppression can affect testicular function and, potentially, fertility. Regulatory information acknowledges this potential effect, underscoring the need for ongoing medical supervision.

Q: What should be done if someone experiences a severe headache while on Testosterone?

A: Official consumer information indicates that headaches should be discussed with a healthcare professional, like a doctor or pharmacist. Furthermore, symptoms associated with serious events may require immediate medical evaluation.

Q: Do studies suggest any potential effects of Testosterone on heart health?

A: Regulatory bodies, including the FDA and EMA, have reviewed available research concerning the potential for cardiovascular risks, such as heart attack and stroke. Official warnings have been issued about a possible increased risk of these events, especially for older men using the medication.

Q: What is the maximum duration of use mentioned in official guidelines?

A: Testosterone therapy is generally intended as a long-term replacement treatment for confirmed hypogonadism (low testosterone). Official guidelines do not typically specify an absolute maximum time limit for use. However, continuation of the therapy is generally subject to periodic monitoring of hormone levels and health status.

Q: Are there any specific foods or drinks that should be avoided with Testosterone?

A: Official product labeling for oral capsules indicates that they should be taken with food to support proper absorption by the body. Regulatory labels generally do not list specific foods or drinks that must be avoided while using this medication.

Q: Why do official sources sometimes mention the potential for psychological effects?

A: Regulatory documents for Testosterone list mood changes and mental depression as possible side effects. Official sources also note that studies examining outcomes related to mood and well-being have produced mixed or inconsistent findings.

Q: Can prescribed Testosterone affect cholesterol levels?

A: Available research suggests that while very high doses of testosterone may be associated with decreased levels of HDL-cholesterol (the “good” cholesterol), replacement therapy for confirmed deficiency is typically associated with only modest changes or no decrease. However, the specific effects observed in an individual can vary.

Q: Does the drug product information describe what happens upon stopping Testosterone treatment?

A: Clinical information indicates that when treatment is discontinued, some physical changes may be permanent, such as a deeper voice and changes to hair growth. However, other effects related to muscle mass or fat distribution are generally not permanent and may revert over time.

Q: What is the difference between primary and secondary hypogonadism in the context of treatment?

A: Product labels primarily use the general term hypogonadism, which means low testosterone production. Clinical information describes the differences between primary hypogonadism, characterized by low testosterone with high pituitary hormones (LH/FSH), and secondary hypogonadism, characterized by low testosterone with normal or low pituitary hormones.

Q: What are the signs of an allergic reaction to a Testosterone product?

A: Hypersensitivity (a severe allergic reaction) to the active ingredient or other components is an official contraindication for use. Signs of a serious allergic reaction described in consumer information include skin rash, itching, hives, or swelling of the face, hands, feet, or lower legs.

Q: What are the known signs of too much Testosterone in the body?

A: Signs that may suggest an excessive level of testosterone or misuse are described in consumer safety documents. These signs can include hyperexcitability, aggression, gynecomastia (male breast enlargement), and high blood pressure. Other physical signs noted are prolonged or painful erections and rapid loss of hair or baldness.

Q: Does taking Testosterone mean I will feel younger or more energetic?

A: Official research indicates that the effects of testosterone on mood and well-being or feelings of fatigue are highly variable among individuals with low testosterone. While some men report improvements in these areas, controlled studies focusing on vitality have shown mixed or inconsistent findings.

Q: Can women be prescribed Testosterone for any condition?

A: Currently, no FDA-approved testosterone products are specifically indicated for use in women in the U.S. or by the EMA in Europe. Furthermore, use is strictly prohibited in women who are pregnant or breastfeeding. Some countries, like Australia, have approved use for certain conditions.

Q: How does Testosterone differ from other hormones or steroid-like medicines?

A: Testosterone is chemically classified as an Androgen and belongs to the steroid hormone class. Its primary function, described in regulatory documents, is to act as an Androgen Receptor agonist, which distinguishes its mechanism of action from other hormone types.

Q: Can I take other prescription medicines with Testosterone?

A: Official documents describe potential interactions between Testosterone and several categories of prescription drugs, including oral anticoagulants, antidiabetic agents, and corticosteroids. Because of the potential for interactions, it is necessary that individuals inform their healthcare provider about all medicines they are taking for necessary monitoring.

Q: Is the term 'hypogonadism' the only condition Testosterone is approved to treat?

A: Testosterone is primarily approved for the treatment of confirmed hypogonadism (low testosterone) in adult males. However, regulatory documents also describe conditional, short-term use in adolescent males with Constitutional Delay of Growth and Puberty.

Q: How long after starting treatment might someone expect to see effects?

A: Official sources indicate that changes related to sexual function, such as increased libido, may begin relatively quickly. However, more significant physical changes, such as those to muscle mass and body composition, typically take several months to become noticeable, with the full progression of effects taking up to 3 to 5 years.

Q: Is Testosterone therapy something I would have to continue forever?

A: Testosterone therapy is categorized as long-term replacement therapy for those diagnosed with hypogonadism. While this may require indefinite continuation, the therapy is always subject to continuous professional monitoring and requires periodic re-evaluation by the prescribing provider.

Q: What specific organs can be affected by Testosterone use, according to official information?

A: Official documents note that adverse effects are documented across several body systems. These include the prostate (risk of enlargement or carcinoma exacerbation), the male breast (carcinoma or gynecomastia), and potential caution for the heart and kidneys due to the risk of fluid retention.

Q: What is the risk of skin transfer with Testosterone gels, as described in product information?

A: The product information for topical gels highlights the risk of secondary exposure, which is the potential transfer of the medicine from the user's skin to other people. To limit this potential transfer, official instructions require the application site to be covered and hands to be washed immediately after application.

Q: Can taking prescribed Testosterone cause hair loss or growth?

A: Official consumer information indicates that taking testosterone can cause changes to body and facial hair, including increased growth, thickening, and darkening. It may also cause loss of hair and baldness (androgenic alopecia) in some individuals.

How should Testosterone (Testosterone) be stored and disposed of?

Storage and Disposal Requirements

Official labeling defines specific conditions for storing testosterone formulations to maintain stability and ensure safety. Injectable Solutions must typically be stored at Controlled Room Temperature mathbf20 to mathbf25 C (68 to mathbf77 F) and be protected from light. Other forms, such as Oral Capsules and Buccal Systems, are stored at room temperature, kept tightly closed in their original containers, and stored away from excess heat and moisture.

Handling and Safety

All testosterone products must be stored out of sight and reach of children and pets. Used single-dose vials and systems, such as the buccal patch, must have their unused portions discarded and be disposed of safely to prevent accidental exposure. Do not flush medication down the toilet unless explicitly instructed to do so; dispose of the product according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Testosterone (Testosterone) found in:

A-Z Index: